High Q Technologies Expands Quantum Protein Analysis Platform For Alzheimer’s Drug Discovery
High Q Technologies Expands Quantum Protein Analysis Platform For Alzheimer’s Drug Discovery
Publish Date: 2026-07-15 10:15:00
Source Domain: thequantuminsider.com
Insider Brief
- High Q Technologies is using a quantum-enabled electron paramagnetic resonance (EPR) platform to help accelerate drug discovery for Alzheimer’s disease and other neurodegenerative disorders by mapping protein motion in greater detail.
- The company’s Fathom system uses quantum sensors to capture multiple protein configurations simultaneously, providing researchers with a more complete view of how proteins behave and interact with potential drug candidates.
- High Q has partnered with contract research organization Creative Biostructure to expand global access to the technology, with support from Canadian government programs, Quantum Valley Investments and the University of Waterloo’s Transformative Quantum Technologies accelerator.
- Photo by Shubham Dhage on Unsplash
An Ontario startup is deploying quantum sensing technology to help pharmaceutical researchers better understand how proteins move, something the company says could shorten drug discovery timelines for Alzheimer’s disease and other neurodegenerative disorders.
High Q Technologies has developed a quantum-enabled electron paramagnetic resonance (EPR) spectroscopy platform called Fathom that measures the motion of proteins in greater detail than many conventional structural biology techniques, according to medical news site MedPath. The company said the approach could help researchers identify and evaluate drug candidates more efficiently by providing a more complete picture of how proteins change shape as they interact with potential therapies.
The technology targets one of the longstanding challenges in drug discovery. Proteins are not fixed structures, but constantly bend, twist and shift between different shapes as they carry out biological functions. Many drugs work by altering those movements, making it important for researchers to understand the full range of protein behavior rather than a single static structure.
According to MedPath, High Q was…
